1014 related articles for article (PubMed ID: 28318947)
1. Docking, synthesis and antimalarial activity of novel 4-anilinoquinoline derivatives.
Vijayaraghavan S; Mahajan S
Bioorg Med Chem Lett; 2017 Apr; 27(8):1693-1697. PubMed ID: 28318947
[TBL] [Abstract][Full Text] [Related]
2. 4-anilinoquinoline triazines: a novel class of hybrid antimalarial agents.
Kumar A; Srivastava K; Kumar SR; Siddiqi MI; Puri SK; Sexana JK; Chauhan PM
Eur J Med Chem; 2011 Feb; 46(2):676-90. PubMed ID: 21194812
[TBL] [Abstract][Full Text] [Related]
3. In vitro antimalarial activity, β-haematin inhibition and structure-activity relationships in a series of quinoline triazoles.
Joshi MC; Wicht KJ; Taylor D; Hunter R; Smith PJ; Egan TJ
Eur J Med Chem; 2013 Nov; 69():338-47. PubMed ID: 24077524
[TBL] [Abstract][Full Text] [Related]
4. Discovery of new antimalarial agents: Second-generation dual inhibitors against FP-2 and PfDHFR via fragments assembely.
Chen W; Huang Z; Wang W; Mao F; Guan L; Tang Y; Jiang H; Li J; Huang J; Jiang L; Zhu J
Bioorg Med Chem; 2017 Dec; 25(24):6467-6478. PubMed ID: 29111368
[TBL] [Abstract][Full Text] [Related]
5. Designing novel inhibitors against falcipain-2 of Plasmodium falciparum.
Himangini ; Pathak DP; Sharma V; Kumar S
Bioorg Med Chem Lett; 2018 May; 28(9):1566-1569. PubMed ID: 29602682
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and antimalarial activity of carbamate and amide derivatives of 4-anilinoquinoline.
Delarue-Cochin S; Grellier P; Maes L; Mouray E; Sergheraert C; Melnyk P
Eur J Med Chem; 2008 Oct; 43(10):2045-55. PubMed ID: 18226428
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and in vitro and in vivo antimalarial activity of new 4-anilinoquinolines.
Delarue S; Girault S; Maes L; Debreu-Fontaine MA; Labaeïd M; Grellier P; Sergheraert C
J Med Chem; 2001 Aug; 44(17):2827-33. PubMed ID: 11495593
[TBL] [Abstract][Full Text] [Related]
8. Novel series of 1,2,4-trioxane derivatives as antimalarial agents.
Rudrapal M; Chetia D; Singh V
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1159-1173. PubMed ID: 28870093
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of new antimalarial phenylurenyl chalcone derivatives.
Domínguez JN; León C; Rodrigues J; Gamboa de Domínguez N; Gut J; Rosenthal PJ
J Med Chem; 2005 May; 48(10):3654-8. PubMed ID: 15887974
[TBL] [Abstract][Full Text] [Related]
10. A prodrug form of a Plasmodium falciparum glutathione reductase inhibitor conjugated with a 4-anilinoquinoline.
Davioud-Charvet E; Delarue S; Biot C; Schwöbel B; Boehme CC; Müssigbrodt A; Maes L; Sergheraert C; Grellier P; Schirmer RH; Becker K
J Med Chem; 2001 Nov; 44(24):4268-76. PubMed ID: 11708927
[TBL] [Abstract][Full Text] [Related]
11. Quinoline antimalarials containing a dibemethin group are active against chloroquinone-resistant Plasmodium falciparum and inhibit chloroquine transport via the P. falciparum chloroquine-resistance transporter (PfCRT).
Zishiri VK; Joshi MC; Hunter R; Chibale K; Smith PJ; Summers RL; Martin RE; Egan TJ
J Med Chem; 2011 Oct; 54(19):6956-68. PubMed ID: 21875063
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, Docking, In Vitro and In Vivo Antimalarial Activity of Hybrid 4-aminoquinoline-1,3,5-triazine Derivatives Against Wild and Mutant Malaria Parasites.
Bhat HR; Singh UP; Gahtori P; Ghosh SK; Gogoi K; Prakash A; Singh RK
Chem Biol Drug Des; 2015 Sep; 86(3):265-71. PubMed ID: 25487527
[TBL] [Abstract][Full Text] [Related]
13. New quinoline derivatives demonstrate a promising antimalarial activity against Plasmodium falciparum in vitro and Plasmodium berghei in vivo.
Soares RR; da Silva JM; Carlos BC; da Fonseca CC; de Souza LS; Lopes FV; de Paula Dias RM; Moreira PO; Abramo C; Viana GH; de Pila Varotti F; da Silva AD; Scopel KK
Bioorg Med Chem Lett; 2015 Jun; 25(11):2308-13. PubMed ID: 25920564
[TBL] [Abstract][Full Text] [Related]
14. Bisquinolines. 2. Antimalarial N,N-bis(7-chloroquinolin-4-yl)heteroalkanediamines.
Vennerstrom JL; Ager AL; Dorn A; Andersen SL; Gerena L; Ridley RG; Milhous WK
J Med Chem; 1998 Oct; 41(22):4360-4. PubMed ID: 9784111
[TBL] [Abstract][Full Text] [Related]
15. New 4-aminoquinoline Mannich base antimalarials. 1. Effect of an alkyl substituent in the 5'-position of the 4'-hydroxyanilino side chain.
Raynes KJ; Stocks PA; O'Neill PM; Park BK; Ward SA
J Med Chem; 1999 Jul; 42(15):2747-51. PubMed ID: 10425085
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, and structure-activity relationship studies of 4-quinolinyl- and 9-acrydinylhydrazones as potent antimalarial agents.
Fattorusso C; Campiani G; Kukreja G; Persico M; Butini S; Romano MP; Altarelli M; Ros S; Brindisi M; Savini L; Novellino E; Nacci V; Fattorusso E; Parapini S; Basilico N; Taramelli D; Yardley V; Croft S; Borriello M; Gemma S
J Med Chem; 2008 Mar; 51(5):1333-43. PubMed ID: 18278859
[TBL] [Abstract][Full Text] [Related]
17. New compounds hybrids 1h-1,2,3-triazole-quinoline against Plasmodium falciparum.
Boechat N; Ferreira Mde L; Pinheiro LC; Jesus AM; Leite MM; Júnior CC; Aguiar AC; de Andrade IM; Krettli AU
Chem Biol Drug Des; 2014 Sep; 84(3):325-32. PubMed ID: 24803084
[TBL] [Abstract][Full Text] [Related]
18. Novel phenothiazine antimalarials: synthesis, antimalarial activity, and inhibition of the formation of beta-haematin.
Kalkanidis M; Klonis N; Tilley L; Deady LW
Biochem Pharmacol; 2002 Mar; 63(5):833-42. PubMed ID: 11911834
[TBL] [Abstract][Full Text] [Related]
19. N-cinnamoylation of antimalarial classics: quinacrine analogues with decreased toxicity and dual-stage activity.
Gomes A; Pérez B; Albuquerque I; Machado M; Prudêncio M; Nogueira F; Teixeira C; Gomes P
ChemMedChem; 2014 Feb; 9(2):305-10. PubMed ID: 24474655
[TBL] [Abstract][Full Text] [Related]
20. Antimalarial activity of 4-amidinoquinoline and 10-amidinobenzonaphthyridine derivatives.
Korotchenko V; Sathunuru R; Gerena L; Caridha D; Li Q; Kreishman-Deitrick M; Smith PL; Lin AJ
J Med Chem; 2015 Apr; 58(8):3411-31. PubMed ID: 25654185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
